("20924675" or "20063275" or "23429029" or "9378393" or "17327194" or "26025992" or "18836636" or "19186089" or "15073160" or "30792777" or "28331803" or "24926170" or "15040937").ui
(13 articles)




22421720
Girotra, Mohit et al. “Clinical predictors of fulminant colitis in patients with Clostridium difficile infection.” Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association vol. 18,2 (2012): 133-9. doi:10.4103/1319-3767.93820
^ probably would not meet inclusion criteria - no mention of IVIG anywhere
   
   20924675
   Intravenous Immunoglobulin for the Treatment of Clostridium difficile Infection: A Review DOI 10.1007/s10620-010-1411-2
   
   20063275
   Intravenous immunoglobulin for the treatment of severe Clostridium difficile colitis: an observational study and review of the literature J Hosp Med, 5 (2010), pp. E1-E9
   
   32057278 - NOT FULLY INDEXED - review for free-text keywords
   Clinical management of severe, fulminant, and refractory Clostridioides difficile infection https://proxy.qualtrics.com/proxy/?url=https%3A%2F%2Fdoi.org%2F10.1080%2F14787210.2020.1730814&token=l5LUi8cnPMnderHkqTQ38vX4Rrp1GO%2F7pSEonnUgeys%3D
   
   23429029
   Abdulaziz S, Abou-Shala N, Al-Tarifi A, et al Salvage immunotherapy for fulminant pseudomembranous colitis Case Reports 2013;2013:bcr2012008786.
   
   Not indexed in MEDLINE (i'm guessing this is a meeting abstract)
   Park, Connie MD; Chun, Alexander MD 1592 Treatment of Severe Clostridioides difficile Infection With Intravenous Immunoglobulin, The American Journal of Gastroenterology: October 2019 - Volume 114 - Issue - p S887-S888 doi: 10.14309/01.ajg.0000595896.09276.33
   
   Not indexed in MEDLINE (i'm guessing this is a meeting abstract)
   Nasser, Maliha MD1; Naeem, Asad2; Kumar, Sarwan MD3 Failed Intravenous Immunoglobulin (IVIG) Treatment for Severe Complicated C. difficile Colitis: A Case Report and Literature Review, American Journal of Gastroenterology: October 2017 - Volume 112 - Issue - p S858-S859
   
   add?
   https://pubmed.ncbi.nlm.nih.gov/1901084/
   NO - it's pediatric: Leung DY, Kelly CP, Boguniewicz M, Pothoulakis C, LaMont JT, Flores A. Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin. J Pediatr. 1991;118(4 Pt 1):633-637. doi:10.1016/s0022-3476(05)83393-1
   https://pubmed.ncbi.nlm.nih.gov/9378393/
   Salcedo J, Keates S, Pothoulakis C, et al. Intravenous immunoglobulin therapy for severe Clostridium difficile colitis. Gut. 1997;41(3):366-370. doi:10.1136/gut.41.3.366
   
   Google Scholar: "Immune globulin clostridium difficile"
   https://pubmed.ncbi.nlm.nih.gov/17327194/
   Juang P, Skledar SJ, Zgheib NK, et al. Clinical outcomes of intravenous immune globulin in severe clostridium difficile-associated diarrhea. Am J Infect Control. 2007;35(2):131-137. doi:10.1016/j.ajic.2006.06.007
   //CC says this is relevant 3/4/21
   https://pubmed.ncbi.nlm.nih.gov/26025992/
   Shah PJ, Vakil N, Kabakov A. Role of intravenous immune globulin in streptococcal toxic shock syndrome and Clostridium difficile infection. Am J Health Syst Pharm. 2015;72(12):1013-1019. doi:10.2146/ajhp140359
   
   From WOS:
   https://pubmed.ncbi.nlm.nih.gov/18836636/
   Koulaouzidis A, Tatham R, Moschos J, Tan CW. Successful treatment of Clostridium difficile colitis with intravenous immunoglobulin. J Gastrointestin Liver Dis. 2008;17(3):353-355.
   https://pubmed.ncbi.nlm.nih.gov/19186089/
   O'Horo J, Safdar N. The role of immunoglobulin for the treatment of Clostridium difficile infection: a systematic review. Int J Infect Dis. 2009;13(6):663-667. doi:10.1016/j.ijid.2008.11.012
   
   3/4/21 added the following flagged as relevant CC and coauthors:
   https://pubmed.ncbi.nlm.nih.gov/15073160/
   Wilcox MH. Descriptive study of intravenous immunoglobulin for the treatment of recurrent Clostridium difficile diarrhoea. J Antimicrob Chemother. 2004;53(5):882-884. doi:10.1093/jac/dkh176
   https://pubmed.ncbi.nlm.nih.gov/30792777/
   Chandrasekar T, Naqvi N, Waddington A, et al. Intravenous immunoglobulin therapy for refractory Clostridium difficile toxin colitis in chronic kidney disease: case reports and literature review. NDT Plus. 2008;1(1):20-22. doi:10.1093/ndtplus/sfm008
   https://pubmed.ncbi.nlm.nih.gov/28331803/
   Coffman K, Chen XJ, Okamura C, Louie E. IVIG - A cure to severe refractory NAP-1 Clostridium difficile colitis? A case of successful treatment of severe infection, which failed standard therapy including fecal microbiota transplants and fidaxomicin. IDCases. 2017;8:27-28. Published 2017 Mar 6. doi:10.1016/j.idcr.2017.03.002
   https://pubmed.ncbi.nlm.nih.gov/24926170/
   Shah N, Shaaban H, Spira R, Slim J, Boghossian J. Intravenous immunoglobulin in the treatment of severe clostridium difficile colitis. J Glob Infect Dis. 2014;6(2):82-85. doi:10.4103/0974-777X.132053
   https://pubmed.ncbi.nlm.nih.gov/15040937/
   Giannasca PJ, Warny M. Active and passive immunization against Clostridium difficile diarrhea and colitis. Vaccine. 2004;22(7):848-856. doi:10.1016/j.vaccine.2003.11.030 (also in Embase)
   
   
   
